Immunome, Inc. (IMNM)
23.88
+1.47
(+6.56%)
USD |
NASDAQ |
Jan 20, 16:00
23.83
-0.05
(-0.21%)
After-Hours: 20:00
Immunome Market Cap: 2.190B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 931.97B |
| Amphastar Pharmaceuticals, Inc. | 1.192B |
| Relay Therapeutics, Inc. | 1.284B |
| Prelude Therapeutics, Inc. | 115.67M |
| Context Therapeutics, Inc. | 141.49M |
Market Cap Related Metrics
| PS Ratio | 195.58 |
| Price to Book Value | 8.298 |
| Price | 23.88 |
| Earnings Yield | -12.38% |